Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts()()

Patient-Derived Xenografts (PDXs), entailing implantation of cancer specimens in immunocompromised mice, are emerging as a valuable translational model that could help validate biologically relevant targets and assist the clinical development of novel therapeutic strategies for gastric cancer. More...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neoplasia
Main Authors: Corso, Simona, Cargnelutti, Marilisa, Durando, Stefania, Menegon, Silvia, Apicella, Maria, Migliore, Cristina, Capeloa, Tania, Ughetto, Stefano, Isella, Claudio, Medico, Enzo, Bertotti, Andrea, Sassi, Francesco, Sarotto, Ivana, Casorzo, Laura, Pisacane, Alberto, Mangioni, Monica, Sottile, Antonino, Degiuli, Maurizio, Fumagalli, Uberto, Sgroi, Giovanni, Molfino, Sarah, De Manzoni, Giovanni, Rosati, Riccardo, De Simone, Michele, Marrelli, Daniele, Saragoni, Luca, Rausei, Stefano, Pallabazzer, Giovanni, Roviello, Franco, Cassoni, Paola, Sapino, Anna, Bass, Adam, Giordano, Silvia
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press 2018
נושאים:
Original article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915970/
https://ncbi.nlm.nih.gov/pubmed/29574251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2018.02.003
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים